8:00 AM ET
8-K
Other 8-K Filing
Neuphoria Therapeutics Other 8-K Filing
Neuphoria Therapeutics Inc. has extended its existing shareholder rights agreement (poison pill) for an additional year. The amendment extends the final expiration date of the rights from October 27, 2026, to October 27, 2027. This corporate governance measure is typically used to deter unsolicited takeover attempts by making a hostile acquisition significantly more expensive.
- Counterparty
- Computershare Trust Company, N.A.
- Term
- 1 year